Sildenafil sublingual spray formulations
US9662334B2 · kind B2 · utility
1Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 2016 |
| Grant date | May 30, 2017 |
| Priority date | — |
| Expiry date | Apr 2, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to sublingual spray formulations containing sildenafil. The invention is further directed to methods of treating male sexual dysfunction or pulmonary arterial hypertension by administering sublingual spray formulations containing sildenafil to patients in need of such treatments.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.